Otakoidler

Murray K. R. Mayes A.P. Granner K.D. Roodwell W. V. Harper’ın Biyokimyası

Karatas Y. Histamin ve Antihistaminiklerin Klinik Farmakolojisi. Turkiye Klinikleri J Int Med Sci 2005;1(1):55-66

Altınkurt O. Farmakoloji 1. Ankara Üniversitesi Eczacılık Fakültesi Yayınları. No:54

Özlüoğlu L. N. Saydam L. Kızılay A. Antihistaminikler. K.B.B. ve Baş Boyun Cerrahisi Dergisi, Cilt: 2 Sayı: l, 1994

Kalıner M. A. Nonsedatign antihistamines. Pharmocology Clinical efficacy and adverse effects Am-Far-Physician 45 (3) : 1337-42. 1992.

Meltzer E. O. Comparative Safety of Hl Antihistamines Ann-Allergy 67 (6) : 625-333, 1991

Shamburek R. D. Schubert M. L. Control of gastric acid secretion. Gastroenterology Clinic of North America 1992; 21(3): 527-550

Acet A. Ölmez E. Histamin H2 reseptör blokörleri. Turgut Özal Tıp Merkezi Dergisi. 1(1): 1994

Bulut İ. Mast Hücre Stabilizatörleri. Turkiye Klinikleri J Allergy-Special Topics 2012;5(1):40-4

Tuncer M. Serotonin agonist ve antagonistleri. Kayaalp SA (ed). Rasyonel Tedavi Yönünden Tıbbi Farmakoloji. 9.baskı. Ankara, Hacettepe-Tafl Kitapçılık Ltd. 2000; 1490–1499.

Sağlam E. Yarış E. Bilge S. Serotonin ve Gastrointestinal Sistem. O.M.Ü Tıp Dergisi. 2003. 20(4): 217–223

Gören B. Fen T. Anjiyotensin Reseptör Antagonistleri. T Klin J Cardiol 2003, 16

Singh D. K. Karnik S. S. Angiotensin Receptors: Structure, Function, Signaling and Clinical Applications. J Cell Signal. 2016 June ; 1(2)

Dursun D. Kozan Ö. Anjiyotensin reseptör blokerlerinin kardiyovasküler süreçteki yerleri. Türk Kardiyol Dern Arş - Arch Turk Soc Cardiol 2013;41 Suppl 5:10-17

Campbell J. D. Renin inhibitors - mechanisms of action. Experımental And Clınıcal Pharmacology. 2009;32:132-5

Saito Y, Nakao K, Itoh IT, et al. Endothelin in human plazma and culture medium of aortic endothelial cells: Detection and characterization with radioimmunoassay using monoclonal antibody. Biochem Biophys Res Commun 1989; 161:320-6.

Takahashi, K, Brooks RA, Kanse SM, Ghatei MA, Kohner EM, Bloom SR. Production of endothelin 1 by cultured bovine retinal endothelial cells and presence of endothelin receptors on associated pericytes. Diabetes 1989;38:1200-1202.

Nyborg NC, Pieto D, Benedito S, Nielsen PJ. Role of the endothelium in acetylcholine-induced relaxation and spontaneous tone of bovine isolated retinal small arteries. Invest Ophthalmol Vis Sci. 1991; 32: 27- 31.

Güden S. D. Tunçtan B. Endotelin-1’in Diyabet Patojenezindeki Rolü. MÜSBED 2014;4(3):158-167

Yanaglsawa M, Kurihara H, Kimura S. e! al. A novel patent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332:411 -5.

Seo Bonggwon, Oemar Barry S, Sebenman Robert, Segesser B, von Ludwig, LuscherTF. Both ETA and ETB Receptors Mediate Contraction to Endothelin-1 in Human blood vessels. Circulation 1994; 89:1203-8

Gültekin N. Yaldıran A. Özbayrakçı S. Küçükoğlu S. Mutlu H. Endotelin Sistemi. T Klin Kardiyoloji 1994, 7:4

Oldfield V. Lyseng-Williamson KA. Bosentan: a review of its use in pulmonary arterial hypertension and systemic sclerosis. Am J Cardiovasc Drugs. 2006;6(3):189-20

Costa L. N. P . Sirois P. Tannock l F. Chammas R. The role of kinin receptors in cancer and therapeutic opportunities. Cancer Letters 345 (2014) 27–38

O'Connor TM. O'Connell J. O'Brien DI. Goode T. Bredin CP. Shanahan F. The role of substance P in inflammatory disease. J Cell Physiol. 2004 Nov;201(2):167-80.

Mantyh P.W. Neurobiology of substance P and the NK1 receptor. J Clin Psychiatry. 2002;63 Suppl 11:6-10.

Kanık A. Baran M. Çayan Ö. Eliaçık K. Özdemir T. Helvacı M. Çeçen E. Kronik sulu ishal ve hipokalemiye neden olan vazoaktif intestinal polipeptit salgılayan tümör. Türk Ped Arş 2014; 49: 160-2.

Kasperska-Zajac A. Brzoza Z. Rogala B. Platelet-activating factor (PAF): a review of its role in asthma and clinical efficacy of PAF antagonists in the disease therapy. Recent Pat Inflamm Allergy Drug Discov. 2008 Jan;2(1):72-6.

Edwards LJ. Constantinescu CS. Platelet activating factor/platelet activating factor receptor pathway as a potential therapeutic target in autoimmune diseases. Inflamm Allergy Drug Targets. 2009 Jul;8(3):182-90.

Yıldırım E. A. Turhan S. Anksiyete, Stres ve Yeme Davranışında Nöropeptid Y. Düşünen Adam; 2002, 15(3): 173-181

Göçmen C. Lipid Kökenli Otakoidler:Prostaglandinler ve Lökotrienler. Turkiye Klinikleri J Int Med Sci 2005;1(1):1-9